96 related articles for article (PubMed ID: 21633637)
1. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.
Chu JH; Wang H; Ye Y; Chan PK; Pan SY; Fong WF; Yu ZL
World J Gastroenterol; 2011 May; 17(19):2379-88. PubMed ID: 21633637
[TBL] [Abstract][Full Text] [Related]
2. Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers.
Kwan HY; Niu X; Dai W; Tong T; Chao X; Su T; Chan CL; Lee KC; Fu X; Yi H; Yu H; Li T; Tse AK; Fong WF; Pan SY; Lu A; Yu ZL
Sci Rep; 2015 Mar; 5():9114. PubMed ID: 25766252
[TBL] [Abstract][Full Text] [Related]
3. Sodium butyrate alleviates free fatty acid-induced steatosis in primary chicken hepatocytes via the AMPK/PPARα pathway.
Ding J; Liu J; Chen J; Cheng X; Cao H; Guo X; Hu G; Zhuang Y
Poult Sci; 2024 Apr; 103(4):103482. PubMed ID: 38387286
[TBL] [Abstract][Full Text] [Related]
4. Schisandrin B-mediated TH17 cell differentiation attenuates bowel inflammation.
Ma Z; Xu G; Shen Y; Hu S; Lin X; Zhou J; Zhao W; Liu J; Wang J; Guo J
Pharmacol Res; 2021 Apr; 166():105459. PubMed ID: 33545313
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants of schisandrin B which enhance mitochondrial functional ability and glutathione status as well as heat shock protein expression in rat hearts and H9c2 cells.
Ko KM; Chiu PY
Mol Cell Biochem; 2005 Aug; 276(1-2):227-34. PubMed ID: 16132705
[TBL] [Abstract][Full Text] [Related]
6. Oleic acid-induced steatosis model establishment in LMH cells and its effect on lipid metabolism.
Song H; Yang R; Zhang J; Sun P; Xing X; Wang L; Sairijima T; Hu Y; Liu Y; Cheng H; Zhang Q; Li L
Poult Sci; 2023 Jan; 102(1):102297. PubMed ID: 36446267
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin B enhances embryo competence and potentially mitigates endoplasmic reticulum stress during porcine preimplantation development.
Li C; Ji KB; Choi HY; Liu H; Kim M
Theriogenology; 2024 May; 220():26-34. PubMed ID: 38460201
[TBL] [Abstract][Full Text] [Related]
8. Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis.
Aoudjehane L; Gautheron J; Le Goff W; Goumard C; Gilaizeau J; Nget CS; Savier E; Atif M; Lesnik P; Morichon R; Chrétien Y; Calmus Y; Scatton O; Housset C; Conti F
Dis Model Mech; 2020 Apr; 13(4):. PubMed ID: 32094147
[TBL] [Abstract][Full Text] [Related]
9. Bibenzyl and naphthalene derivatives from Dendrobium chrysanthum and their anti-hepatic-steatosis activities.
Zhang ZM; Chen JM; Wang XX; Wang LY; Liu S; Wang J; Wang YN; Zhuang PY; Wang LL; Liu H
Bioorg Chem; 2024 Apr; 145():107236. PubMed ID: 38402796
[TBL] [Abstract][Full Text] [Related]
10. Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches.
Ortega-Vallbona R; Méndez R; Tolosa L; Escher SE; Castell JV; Gozalbes R; Serrano-Candelas E
Toxicology; 2024 May; 504():153764. PubMed ID: 38428665
[TBL] [Abstract][Full Text] [Related]
11. Unsaponifiable Matter from Wheat Bran Cultivated in Korea Inhibits Hepatic Lipogenesis by Activating AMPK Pathway.
An M; Heo H; Park J; Jeong HS; Kim Y; Lee J
Foods; 2023 Nov; 12(21):. PubMed ID: 37959135
[TBL] [Abstract][Full Text] [Related]
12. Schisandrin B Suppresses Colon Cancer Growth by Inducing Cell Cycle Arrest and Apoptosis: Molecular Mechanism and Therapeutic Potential.
Co VA; El-Nezami H; Liu Y; Twum B; Dey P; Cox PA; Joseph S; Agbodjan-Dossou R; Sabzichi M; Draheim R; Wan MLY
ACS Pharmacol Transl Sci; 2024 Mar; 7(3):863-877. PubMed ID: 38481680
[TBL] [Abstract][Full Text] [Related]
13. Adverse outcome pathway-based analysis of liver steatosis in vitro using human liver cell lines.
Karaca M; Fritsche K; Lichtenstein D; Vural Ö; Kreuzer K; Alarcan J; Braeuning A; Marx-Stoelting P; Tralau T
STAR Protoc; 2023 Sep; 4(3):102500. PubMed ID: 37616165
[TBL] [Abstract][Full Text] [Related]
14. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG
PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy.
Zhou SW; Zhang M; Zhu M
Mol Med Rep; 2014 Nov; 10(5):2351-7. PubMed ID: 25230688
[TBL] [Abstract][Full Text] [Related]
16. Taurine Protects against the Fatty Liver Hemorrhagic Syndrome in Laying Hens through the Regulation of Mitochondrial Homeostasis.
San J; Hu J; Pang H; Zuo W; Su N; Guo Z; Wu G; Yang J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373507
[TBL] [Abstract][Full Text] [Related]
17. An
Lam HYP; Hung MY; Liang TR; Peng SY
Iran J Pharm Res; 2021; 20(4):300-314. PubMed ID: 35194448
[TBL] [Abstract][Full Text] [Related]
18. Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice.
Ma R; Zhan Y; Zhang Y; Wu L; Wang X; Guo M
Drug Dev Res; 2022 May; 83(3):735-744. PubMed ID: 34927282
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of Schisandrin B against D-GalN-induced cell apoptosis in human hepatocyte (L02) cells via modulating Bcl-2 and Bax.
Hu Y; Li H; Li R; Tian Y; Wu Z
Bioengineered; 2021 Dec; 12(1):7205-7214. PubMed ID: 34546847
[TBL] [Abstract][Full Text] [Related]
20. Val-Val-Tyr-Pro protects against non-alcoholic steatohepatitis in mice by modulating the gut microbiota and gut-liver axis activation.
Xie X; Zhang L; Yuan S; Li H; Zheng C; Xie S; Sun Y; Zhang C; Wang R; Jin Y
J Cell Mol Med; 2021 Feb; 25(3):1439-1455. PubMed ID: 33400402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
